Europace

Article	Citations
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	525
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	366
Impact of pulsed-field ablation on kidney function	308
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	264
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	228
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	215
Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	180
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	174
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	158
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	152
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	146
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	133
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	116
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	115
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	113
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	111
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	106
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	105
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	102
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	100
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	94
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	90
Computed tomography as a predictive tool for ventricular tachycardia	82
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	82
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	79

Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	73
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	72
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	68
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	67
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	66
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	66
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	65
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	65
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	64
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	62
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	61
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	61
First experience of focal pulsed field ablation for premature ventricular contractions	61
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	60
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	59
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	59
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	57
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	57
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	56
MicroPort CRM considerations on Vega pacing lead performance	55
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	55
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	55
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	54
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	53
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	52
LAT velocity vectors: a novel tool for ventricular functional substrate characterization	52
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	52
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	51
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	50
Does the rhythm have an additional effect - left atrial strain measurement in heart failure patients with HFrEF and in patients with atrial fibrillation and preserved ejection fraction	50
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	50
Ultra-high density mapping and ablation of localized microreentrant tachycardias: insight from the CHARISMA registry	50
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database	50
Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis	49
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	48
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	48
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation	48
Simplification of resetting response in slow/fast atrioventricular nodal reentrant tachycardia: the 3 catheters approach	47
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	47
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	47
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	47
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	47
Imaging-derived tissue visualization guides catheter ablation of premature ventricular contractions	46
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	45
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators	45
Jailed or freed? The lead dilemma in transcatheter tricuspid valve replacement	44
Atrial cardiomyopathy delays the endothelialization process of left atrial appendage occluders	44
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of ‘ground truth’	44
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	43
Promoting differentiation of human-induced pluripotent stem cells into sinoatrial node-like cells through programmed regulation of AMPK signalling pathway	43

Permanent epicardial pacing : a first line strategy in children	43
Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events	43
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	42
Novel four-exon deletion in ryanodine receptor gene (RYR2) associated with mixed electric and structural cardiac phenotype	42
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	42
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	42
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	41
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients	40
Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	40
Prevalence and characteristics of arrhythmias during the pregnancy	40
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall	39
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry	39
Correction to: Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology	39
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	39
Underlying reasons for sex difference in survival following out-of-hospital cardiac arrest: a mediation analysis	38
Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial	38
Manual compression versus modified figure-of-8 stitch after left atrial ablations: a comparative randomized trial	38
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	37
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review	37
Carbon footprint of atrial fibrillation catheter ablation	36
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?	36
Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness?	36
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	36
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), an	36
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network	36
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review	35
Cardioneuroablation for treatment of atrioventricular block: to cure the patient or the electrocardiogram?	35
Device-lead abnormalities and function after transcatheter tricuspid valve replacement	35
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	34
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	34
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	34
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	34
Transvenous lead extraction: Experience of the Tandem approach	34
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	34
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy	33
Distribution of Peri-Device Leaks on TEE and Cardiac CT After WATCHMAN Implantation: A Multicenter Core-Lab Analysis	33
Corrigendum to: Infanticide vs. inherited cardiac arrhythmias	32
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	32
Long-term outcome after catheter ablation for fascicular ventricular tachycardia in a single high-volume center in Germany	32
Comparison of quality-of-life following cryoballoon versus radiofrequency catheter ablation of symptomatic atrial fibrillation - a subanalysis of the FREEZE cohort study	32
Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study	32
Left-bundle branch block, an alert for cardiac resynchronization therapy	32
Predicting dementia in patients with atrial fibrillation using machine learning of a large multimodal registry	32
Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz	32
In memoriam: Stuart J. Connolly, MD, 9 April 1949–2 June 2024	32
Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis	31
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?	31
Biatrial ablation versus left atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease undergoing valve surgery: a systematic review and meta-analysis	31
Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation	31
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation	31
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation	30
Volume-weighted unipolar voltage identifies diffuse fibrosis in patients with non-ischemic cardiomyopathy	30
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation	30
Pulmonary vein isolation with additional substrate ablation for atrial fibrillation results in an increased risk for the development of atypical atrial flutter	30
Evidence for a shift from right ventricular to left ventricular outflow tract origin of idiopathic premature ventricular contractions with advancing age	30
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation	30
Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection	30
Non-standard approach for device selection. Left bundle branch optimized ICD for patients with heart failure and LBBB	30
What determines who gets cardiac resynchronization therapy in europe?	29
Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation	29
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis	29
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project	29
Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation	29
Very-early detection of atrial fibrillation in patients after ablation evaluated by a home-based wearable ECG-patch	28
Non-invasive identification of deceleration zones in the atria using imageless ECGI: correlation with contact-mapping	28
Electrophysiologic effects of left bundle branch area pacing: comparing left ventricular septal pacing and left bundle branch pacing	28
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarisation analysed from 5-minute resting electrocardiogram in coronary artery disease	28
Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy	28
Renal denervation for the management of refractory ventricular arrhythmias	27
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study	27
Identifying (electrophysiological) predictors of atrial fibrillation recurrences after catheter ablation: first results from the ISOLATION registry	27
Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm	27
Weight-loss management after catheter ablation of atrial fibrillation	27
Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?	27
Optimal timing of of cardiac implantable electronic device reoperation	27
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study	27
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome	27
Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation	27
First-line Marshall plan approach in persistent atrial fibrillation: a prospective single-center cohort study	27
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis	26

Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation	26
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden	26
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type	26
360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation	26
Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker	26
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation	26
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions	26
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial	26
Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility, and diagnostic value in complex ablation procedures	26
How to ablate the septo-pulmonary bundle: a case-based review of percutaneous ablation strategies to achieve roof line block	25
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates	25
Validation of a machine learning algorithm to identify pulmonary vein isolation during ablation procedures for the treatment of atrial fibrillation: results of the PVISION study	25
Genetic testing in children with Brugada syndrome: results from a large prospective registry	25
Leap or lag: left atrial appendage closure and guidelines	25
Use of three-dimensional electroanatomic mapping for epicardial access: needle tracking, electrographic characteristics, and clinical application	25
Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk	25
Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing	25
The effect of thresholding techniques on 3D quantitative scar metrics in patients with implantable cardioverter defibrillator	25
A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study)	25
Ventricular septal defect characteristics influence presence and properties of septal anatomical isthmuses in patients with repaired tetralogy of Fallot	25
Markers of atrial myopathy in the UK Biobank: prevalence, consequences, and risk stratification	25
Pinpointing atrial fibrillation drivers by informed sequential endocardial mapping in the presence and absence of fibrosis: an in-silico study	25
A novel score to predict left atrial appendage thrombus and sludge in patients with persistent atrial fibrillation on chronic anticoagulants	24
Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?	24
AV block occurrence in normal AV conduction CRT fusion pacing: single center experience	24
Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures	24
Atrial fibrillation and heart failure temporality: does it matter?	24
EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit	24
Vascular complications of pulsed-field ablation of atrial fibrillation using a streamlined procedural workflow - when less is not more	24
Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience	24
Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic	24
Software-based analysis of T-wave morphology: identifying the electrocardiogram signature of high-risk long QT syndrome	24
Influence of Dielectric Perfusate on pulsed-field ablation-Induced Hemolysis	24
Current practice in the management of syncope in Italian hospitals: a national survey	24
High comorbidity burden is not associated with increased risk of periprocedural pericardial effusionduring left atrial ablation procedures: data from a large tertiary-care ablation center	24
Novelty about pocket histology at cardiac implantable electronic device reopening procedures	24
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study	24
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’ approach	24
Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease	24
Re-recognized the maintenance mechanism of persistent atrial fibrillation via electrogram analysis in termination regions	24
In silico biatrial fibrosis ablation improves atrial fibrillation outcome	23
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family	23
Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source	23
Additional coils mitigate elevated defibrillation threshold in right-sided implantable cardioverter defibrillator generator placement: a simulation study	23
Wearable Smartwatches for Atrial Fibrillation Detection and Burden Estimation After Ablation: Comparison With Continuous Monitoring	23
Mapping and ablation outcomes of extra-pulmonary vein triggers in atrial fibrillation: single-centre retrospective study with consistent provocation protocol	23
Selective sparing of Purkinje fibres with pulsed-field myocardial ablation	23
Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper	23
Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison	23
Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome	22
Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study	22
Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure	22
A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis	22
Same-day discharge for atrial fibrillation ablation: outcomes and impact of ablation modality	22
Deep septal pacing for pacemaker-induced cardiomyopathy	22
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement	22
Septal venous channel perforation during left bundle branch area pacing: a prospective study	22
Pre- and post-procedural cardiac imaging (computed tomography and magnetic resonance imaging) in electrophysiology: a clinical consensus statement of the European Heart Rhythm Association and European	21
Severe acute kidney injury related to haemolysis after pulsed field ablation for atrial fibrillation	21
Detailed analysis of PAC characteristics in ambulatory ECG data can improve atrial fibrillation risk prediction	21
Worse outcomes in patients with cardiac sarcoidosis and involvement of the right ventricle in cardiac magnetic resonance	21
Progress in atrial fibrillation ablation during 25 years of Europace journal	21
State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective	21
Phosphoproteomics of phospholamban R14del heart tissue reveals aberrant regulation of calcium handling and contractility	21
Assessing V6 RWPT and V6-V1 interpeak time as conduction system capture criteria in non-basal LBBAP lead positions	21
Differential effect of high-frequency electroporation on myocardium vs. non-myocardial tissues	21
Clinical impact of right ventricular pacing burden in patients with post-transcatheter aortic valve replacement permanent pacemaker implantation	21
Does radiotherapy effect the voltage output of cardiac implantable electronic devices (CIEDs)?	21
Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016–2019 national readmission database	21
Testing radiofrequency energy delivery and catheter entrapment in three left ventricular assist device models in mock circulation	20
Non-invasive electrocardiographic mapping using an endo-epicardial system based on extracellular potentials shows better accuracy for atrial arrhythmias than ventricular arrhythmias	20
The effect of different ablation modalities for atrial fibrillation on left atrial remodeling and function	20
Outcomes of tine-based leadless pacemakers retrieval: a multicenter study	20
Efficacy of drug eluting envelopes in reducing infections among pacemaker patients: the REINFORCE real-world data project	20
Adaptive versus conventional cardiac resynchronization therapy in asian heart failure patients with moderately wide QRS: primary results from the Mid-Q Response randomized trial	20
A novel predictive model for differentiating cardiac and non-cardiac syncope in syncope-admitted patients	20
DIGItal health literacy after COVID-19 outbreak among frail and non-frail cardiology patients: the DIGI-COVID study	20
Organization of atrial fibrillation during pulsed field ablation	20
Precordial activation sequences from low frequency analysis in left bundle branch block patients: left bundle branch area pacing vs right ventricular pacing	20
X-ray guided left bundle branch area pacing lead implantation after transcatheter tricuspid valve replacement is feasible and safe	20
Can we predict if defibrillation testing of a subcutaneous implantable cardioverter defibrillator can be avoided safely at device replacement?	20
In vivo KCNH2-suppression-replacement gene therapy attenuates the pathogenic phenotype in transgenic rabbits with short QT syndrome type 1	20
Impact of catheter ablation on erectile dysfunction in atrial fibrillation patients	20
The procedural characteristics of radiofrequency ablation points in patients undergoing atrial fibrillation ablation: comparison between standard vs very high-power short-duration	20
Optimising electrical performance of leadless cardiac resynchronisation therapy and leadless LV septal pacing	20
Feasibility of a transseptal approach for ablation of ventricular arrhythmias in patients after edge-to-edge mitral valve repair	20
High-density open window mapping vs conventional mapping in accessory pathways ablation	19
Enhanced identification of atrial arrhythmic triggers using cardiac digital twins generated from imageless electrocardiographic imaging	19
Single-centre experience with an electrogram-based artificial intelligence software system to identify drivers in pulsed field ablation of persistent atrial fibrillation	19
Clonal hematopoiesis of indeterminate potential and risk of atrial fibrillation: a meta-analysis	19
Temporal stability of local cycle length and duty cycle distribution during atrial fibrillation	19
Effect of atrial extrasystoles in electrophysiological properties in heart failure patients	19
Validation of the Castle HTx data in a real world scenario	19
Atrial fibrillation recurrence after atrial flutter ablation in subjects initially diagnosed as atrial fibrillation: A machine learning approach using XGBoost	19
Clinical and instrumental factors associated with sinus rhythm maintenance following direct current cardioversion of late persistent non-valvular atrial fibrillation at 6-months follow-up	19